Cargando…
Sequential evaluation of CALR mutant burden in patients with myeloproliferative neoplasms
We investigated the variation of CALR-mutant burden during follow-up in 105 CALR-mutant MPN and compared it to the variation of JAK2-mutant burden in 226 JAK2-mutant MPN. The median allele burden at last evaluation was significantly higher than at first evaluation in essential thrombocythemia (ET) (...
Autores principales: | Cavalloni, Chiara, Rumi, Elisa, Ferretti, Virginia V., Pietra, Daniela, Roncoroni, Elisa, Bellini, Marta, Ciboddo, Michele, Casetti, Ilaria C., Landini, Benedetta, Fugazza, Elena, Troletti, Daniela, Astori, Cesare, Cazzola, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464878/ https://www.ncbi.nlm.nih.gov/pubmed/28422716 http://dx.doi.org/10.18632/oncotarget.16797 |
Ejemplares similares
-
Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria
por: Rumi, Elisa, et al.
Publicado: (2017) -
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms
por: Pietra, D, et al.
Publicado: (2016) -
SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms
por: Borsani, Oscar, et al.
Publicado: (2023) -
CALR mutation characterization in myeloproliferative neoplasms
por: Bilbao-Sieyro, Cristina, et al.
Publicado: (2016) -
Risk of Thrombosis in Myeloproliferative Neoplasms after Sars-Cov-2 Vaccination
por: Borsani, Oscar, et al.
Publicado: (2022)